Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral endothelial function on ticagrelor versus clopidogrel after PCI
2015-000334-30Phase 4Completed
- Sponsor
- Professor Thomas John Kiernan
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor and clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Professor Thomas John Kiernan. Primary endpoint: Peripheral endothelial dysfunction proportion difference. Started Mar 2015; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2015-000334-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000334-30.